Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Telecoms Today.
Press releases published on May 20, 2025

8 Rivers Partners with Navajo Transitional Energy Company on Feasibility Study to Develop a Gigawatt of Decarbonized Coal Power
DURHAM, N.C., May 20, 2025 (GLOBE NEWSWIRE) -- 8 Rivers Capital, LLC, (8 Rivers) a world-leading decarbonization technology developer, in collaboration with Siemens Energy, has contracted with the Navajo Transitional Energy Company (NTEC) to conduct a …

Algorhythm Holdings Appoints Ajesh Kapoor to its Board of Directors
Mr. Kapoor Brings more than 30 Years of Supply-Chain, Logistics Technology and Go-To-Market Leadership to the Board Fort Lauderdale, FL, May 20, 2025 (GLOBE NEWSWIRE) -- Algorhythm Holdings, Inc. (“Algorhythm”) (NASDAQ: RIME) – an AI technology and …

aTyr Pharma to Present at Upcoming Investor Conferences
SAN DIEGO, May 20, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced that …

Aventis Energy Provides Recent Exploration Insights at the Corvo Uranium Project
VANCOUVER, British Columbia, May 20, 2025 (GLOBE NEWSWIRE) -- Aventis Energy. (“Aventis” or the “Company”) (CSE: AVE | OTC: VBAMF), is pleased to provide a comprehensive summary of exploration insights and historical data gathered at its Corvo Uranium …

Marine Biologics Expands Leadership Team to Drive Next Phase of Growth
BERKELEY, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- Biomaterials company Marine Biologics today introduced Danièle Karleskind, Ph.D. as its new Chief Operations Officer and Ryan Hunt as Director of Business Development. With more than 55 years of combined …

ALX Oncology Highlights Differentiated Design, Preclinical Data and Development Plans for EGFR-Targeted ADC, ALX2004, in R&D Webcast Event
- A potential best- and first-in-class antibody-drug conjugate (ADC) for the treatment of EGFR-expressing solid tumors, ALX2004 is uniquely designed with every component optimized to maximize the therapeutic window by reducing toxicity - Following recent …

Freshpet, Inc. to Participate in the Deutsche Bank Global Consumer Conference
BEDMINSTER, N.J., May 20, 2025 (GLOBE NEWSWIRE) -- Freshpet, Inc. (“Freshpet” or the “Company”) (Nasdaq: FRPT) today announced that members of the executive management team will participate in the Deutsche Bank Global Consumer Conference in Paris, France. …

Duck Creek Technologies Kicks Off Formation ’25 to Shape Insurance’s Future
BOSTON, May 20, 2025 (GLOBE NEWSWIRE) -- Duck Creek Technologies, the global intelligent solutions provider defining the future of property and casualty (P…

Praxis Precision Medicines to Participate in Upcoming Conferences
BOSTON, May 20, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by …

Expanded Partnership Increases Access to Unified, Intelligent Radiologist Desktops for Radiology Practices
TAMPA, Fla. and WAYNE, N.J., May 20, 2025 (GLOBE NEWSWIRE) -- NewVue, a leader in cloud-native radiology workflow solutions, today announced the expansion of its partnership with Konica Minolta Healthcare Americas, Inc. from a referral agreement to a …

Efficacy Results Announced from Cingulate’s Phase 3 Pediatric Study of CTx-1301 (dexmethylphenidate) for ADHD
Subjects Demonstrated Marked Improvement of ADHD Symptoms at Week 5 New Drug Application on Schedule for this Summer CING CEO Shares Insights and Strategic Outlook on “Unboxing Biotech” Podcast KANSAS CITY, Kan., May 20, 2025 (GLOBE NEWSWIRE) -- Cingulate …

Duos Technologies Appoints Retired Brigadier General Craig Nixon as Chairman of the Board of Directors
JACKSONVILLE, Fla., May 20, 2025 (GLOBE NEWSWIRE) -- Duos Technologies Group, Inc. (“Duos” or the “Company”) (Nasdaq: DUOT), today announced the appointment of Brigadier General (Ret.) James Craig Nixon as the new Chairman of its Board of Directors, …

Spectral AI Research Partner Using DeepView System Wins Best Research Project at the 2025 Education Awards
DALLAS, May 20, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ: MDAI) (“Spectral AI” or the “Company”), a leading developer of the AI-driven DeepView® System, which uses multi-spectral imaging and AI algorithms to predict burn healing potential today …

Mineralys Therapeutics Announces Late-Breaking Presentation of Phase 3 Launch-HTN Trial at 34th European Meeting on Hypertension and Cardiovascular Protection
RADNOR, Pa., May 20, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD), obstructive sleep apnea (OSA) and …

Clear View Building Services Publicizes Longstanding Commercial Cleaning Division
New York, NY, May 20, 2025 (GLOBE NEWSWIRE) -- Clear View Building Services, a trusted provider of professional cleaning solutions since 2001, is proud to formally spotlight its comprehensive commercial cleaning service, now being promoted across media and …

PRECISION CLEANING MANUFACTURER JE CLEANTECH DELIVERS HEALTHY PERFORMANCE IN 2024
Increase in sales by S$1 million for precision cleaning systems and S$0.3 million for the provision of centralized dishwashing and ancillary services in Singapore Overall gross profit margin yield higher compared to the corresponding year SINGAPORE, May 20 …

NeurAxis Awarded First Ever FDA Clearance for the Treatment of Pediatric FAP/Functional Dyspepsia (FD) and Associated Nausea Symptoms
• Significantly expands IB-Stim’s total addressable market • Clearance covers patients aged 8–21 • Seamless go-to-market strategy with existing reimbursement and provider infrastructure CARMEL, Ind., May 20, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“ …

Philikos announces initiation of clinical Phase 1/2 study with T-Guard® in patients with systemic sclerosis
NIJMEGEN, the Netherlands, May 20, 2025 (GLOBE NEWSWIRE) -- Philikos B.V., a Dutch biotechnology company developing antibody-based therapies to treat severe immune disorders, today announced that it has enrolled the first patient in a Phase 1/2 clinical …

Philikos kondigt de start aan van een klinische fase 1/2-studie met T-Guard® bij patiënten met systemische sclerose
NIJMEGEN, the Netherlands, May 20, 2025 (GLOBE NEWSWIRE) -- Philikos B.V., een Nederlands biotechnologiebedrijf dat op antilichamen gebaseerde therapieën ontwikkelt voor de behandeling van ernstige immuunziekten, heeft vandaag aangekondigd dat de eerste …

ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2025
Highlights Multiple Significant Potential Liquidity Events Anticipated Within the Next Few Months Completes Significant Reductions in Overhead and Expenses BE-Smart Esophageal Cancer Test Study has been Submitted in the Journal of Clinical Gastrointestinal …